Interestingly, PTEN- was more frequent among the TN BCBM (seven of 19, 37%) compared with HR+/HER2- (two of 12, 17%) and HER2+ (three of 12, 25%) BC (P = 0.3). The gene discussed is ERBB2; the disease is breast cancer.